S C Bourke

Summary

Country: UK

Publications

  1. ncbi request reprint Non-invasive ventilation in ALS: current practice and future role
    S C Bourke
    Amyotroph Lateral Scler Other Motor Neuron Disord 5:67-71. 2004
  2. ncbi request reprint Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS
    S C Bourke
    University of Newcastle, Newcastle upon Tyne, UK
    Neurology 57:2040-4. 2001
  3. ncbi request reprint Sleep and breathing in neuromuscular disease
    S C Bourke
    University of Newcastle and Freeman Hospital, Newcastle upon Tyne, UK
    Eur Respir J 19:1194-201. 2002
  4. ncbi request reprint Non-invasive ventilation in motor neuron disease: current UK practice
    S C Bourke
    University of Newcastle, Newcastle upon Tyne NE7 7DN, UK
    Amyotroph Lateral Scler Other Motor Neuron Disord 3:145-9. 2002
  5. ncbi request reprint Noninvasive ventilation in ALS: indications and effect on quality of life
    S C Bourke
    University of Newcastle and Freeman Hospital, Newcastle upon Tyne, UK
    Neurology 61:171-7. 2003
  6. pmc Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone
    S C Bourke
    Consultant Respiratory Physician, Northumbria Healthcare Trust and Freeman Hospital, Newcastle upon Tyne, UK
    Thorax 58:1004-5. 2003
  7. ncbi request reprint Validation of quality of life instruments in ALS
    S C Bourke
    Northumbria Healthcare Trust and Freeman Hospital, UK
    Amyotroph Lateral Scler Other Motor Neuron Disord 5:55-60. 2004

Detail Information

Publications7

  1. ncbi request reprint Non-invasive ventilation in ALS: current practice and future role
    S C Bourke
    Amyotroph Lateral Scler Other Motor Neuron Disord 5:67-71. 2004
  2. ncbi request reprint Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS
    S C Bourke
    University of Newcastle, Newcastle upon Tyne, UK
    Neurology 57:2040-4. 2001
    ..Sleep disruption, possibly due to apneas, hypopneas, orthopnea, or REM-related desaturation, is common. The relative impact of these factors on quality of life has not been established...
  3. ncbi request reprint Sleep and breathing in neuromuscular disease
    S C Bourke
    University of Newcastle and Freeman Hospital, Newcastle upon Tyne, UK
    Eur Respir J 19:1194-201. 2002
    ..However, the optimal criteria for initiation of ventilation and its role in rapidly progressive neuromuscular diseases are unclear...
  4. ncbi request reprint Non-invasive ventilation in motor neuron disease: current UK practice
    S C Bourke
    University of Newcastle, Newcastle upon Tyne NE7 7DN, UK
    Amyotroph Lateral Scler Other Motor Neuron Disord 3:145-9. 2002
    ..To evaluate the clinical application of non-invasive ventilation (NIV) in motor neuron disease (MND) in the UK...
  5. ncbi request reprint Noninvasive ventilation in ALS: indications and effect on quality of life
    S C Bourke
    University of Newcastle and Freeman Hospital, Newcastle upon Tyne, UK
    Neurology 61:171-7. 2003
    ..Noninvasive ventilation (NIV) probably improves survival in ALS, but the magnitude and duration of any improvement in quality of life (QoL) and the optimal criteria for initiating treatment are unclear...
  6. pmc Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone
    S C Bourke
    Consultant Respiratory Physician, Northumbria Healthcare Trust and Freeman Hospital, Newcastle upon Tyne, UK
    Thorax 58:1004-5. 2003
    ..He currently remains stable 41 months after treatment was initiated. This is the first report of pulmonary Erdheim-Chester disease showing improvement in both lung function and symptoms with any form of treatment...
  7. ncbi request reprint Validation of quality of life instruments in ALS
    S C Bourke
    Northumbria Healthcare Trust and Freeman Hospital, UK
    Amyotroph Lateral Scler Other Motor Neuron Disord 5:55-60. 2004
    ..Non-invasive ventilation (NIV) probably improves survival in ALS, but its effect on quality of life (QoL) is less clear. Most potentially useful QoL instruments have not been validated in this context...